BRIEF published on 02/19/2025 at 22:10, 9 months 13 days ago Bausch Health Reports Strong Financial Performance in 2024 Adjusted EBITDA Revenue Growth Financial Performance Bausch Health 2024 Results
PRESS RELEASE published on 02/19/2025 at 22:05, 9 months 13 days ago Bausch Health Announces Fourth Quarter and Full-Year 2024 Results Bausch Health Companies Inc. announces strong Q4 and full-year 2024 financial results, achieving revenue growth in all segments and exceeding adjusted EBITDA guidance Financial Results Adjusted EBITDA Revenue Growth Bausch Health Q4 2024
BRIEF published on 02/14/2025 at 14:05, 9 months 18 days ago Bausch Health to Attend J.P. Morgan Finance Conference Healthcare Pharmaceutical Webcast Bausch Health Finance Conference
PRESS RELEASE published on 02/14/2025 at 14:00, 9 months 18 days ago Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference Bausch Health Companies Inc. to participate in 2025 J.P. Morgan Global Leveraged Finance Conference on February 24. Webcast available on Investor Relations section of Bausch Health's website Investor Relations Webcast Conference Bausch Health J.P. Morgan
BRIEF published on 02/10/2025 at 14:05, 9 months 22 days ago Bausch Health Launches 2025 Salix GI Health Scholars Program Salix Pharmaceuticals Bausch Health Higher Education GI Diseases Scholarship Program
PRESS RELEASE published on 02/10/2025 at 14:00, 9 months 22 days ago Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program Bausch Health and Salix Pharmaceuticals launch 2025 Salix Gastrointestinal Health Scholars Program, offering scholarships for students living with GI diseases. Application deadline on May 5, 2025 Salix Pharmaceuticals Bausch Health Scholarships GI Diseases 2025
BRIEF published on 02/06/2025 at 13:10, 9 months 26 days ago Bausch Health Decides Against Sale of Bausch + Lomb Financial Performance Bausch Health Liability Management Bausch + Lomb Sale Decision
PRESS RELEASE published on 02/06/2025 at 13:05, 9 months 26 days ago Bausch Health Provides Update on Strategic Alternatives Bausch Health provides an update on the potential sale of Bausch + Lomb Corporation. The process did not lead to an offer reflecting its long-term value, and the sale will not proceed at this time Financial Advisors Bausch Health Liability Management Bausch + Lomb Sale Update
BRIEF published on 01/23/2025 at 13:05, 10 months 12 days ago Bausch Health to Release Q4 and Full Year 2024 Results Financial Results Investor Relations Webcast Bausch Health Q4 2024
PRESS RELEASE published on 01/23/2025 at 13:00, 10 months 12 days ago Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025 Bausch Health to release Q4 & full year 2024 financial results on Feb 19, 2025, and host conference call. A leading pharmaceutical company focused on healthcare outcomes Financial Results Conference Call Pharmaceutical Company Healthcare Outcomes Bausch Health
Published on 12/05/2025 at 02:35, 8 hours 25 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 10 hours ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 11 hours 55 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 12 hours ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 10:30, 30 minutes ago Tradegate Exchange and Börse Berlin merge to form Tradegate BSX
Published on 12/05/2025 at 10:15, 45 minutes ago Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 1 hour 20 minutes ago Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 1 hour 30 minutes ago REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 1 hour 55 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 08:45, 2 hours 15 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 17 hours ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 17 hours 15 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 17 hours 16 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 3 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
